Best Lab Equipment

Here are some more information for Molecular Imager:

Dilon Technologies Partners With PenRad Mammography Information Systems to Provide Streamlined Diagnostic Analysis and Reporting

Dilon Technologies announced that they have entered into a co-marketing partnership with PenRad Mammography Information Systems. Dilon will introduce the PenRad system to its Dilon 6800 Gamma Camera customers as a tool to effectively streamline patient exam analysis and reporting.

The Dilon 6800 Gamma Camera is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure that images the metabolic activity of breast lesions through radiotracer uptake. The PenRad MIS auditing and tracking system creates efficiencies for clinics and hospitals where BSGI is performed. The software helps facilities meet MQSA requirements by creating reports, patient letters, statistics, analytics, and more. PenRad's unique design benefits the patient, technologist, radiologist and administrative office personnel, increasing the productivity and profitability of a practice.

"This alliance is a natural extension to our Dilon 6800 Gamma Camera and BSGI offering to the physician," said Bob Moussa, President and CEO of Dilon Technologies. "With the PenRad system, our customers can save time, increase efficiency and ease workflow when using BSGI."

BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunct procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on the BSGI image.

"Molecular imaging using BSGI has become an important tool in the quest for early diagnosis of breast cancer," said Greg Gustafson, President of PenRad. "We are excited to partner with Dilon so we can help advance patient care efficiently on the management information side."

Dilon will feature the PenRad alliance at the Radiological Society of North America 2008 annual meeting in Chicago, November 30 through December 5.

About the Author

For more information about PenRad,PenRad Technologies, PenRad Products, Radiology Imaging. Please visit http://www.medicexchange.com/

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities
A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City's African-American and Latino communities.

Thanks for visiting!